181 related articles for article (PubMed ID: 21874310)
1. Disease-free probability after the first primary ductal carcinoma in situ of the breast: a comparison between African-American and White-American women.
Stark A; Stapp R; Raghunathan A; Yan X; Kirchner HL; Griggs J; Newman L; Chitale D; Dick A
Breast Cancer Res Treat; 2012 Jan; 131(2):561-70. PubMed ID: 21874310
[TBL] [Abstract][Full Text] [Related]
2. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Narod SA; Iqbal J; Giannakeas V; Sopik V; Sun P
JAMA Oncol; 2015 Oct; 1(7):888-96. PubMed ID: 26291673
[TBL] [Abstract][Full Text] [Related]
3. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast.
Innos K; Horn-Ross PL
Breast Cancer Res Treat; 2008 Oct; 111(3):531-40. PubMed ID: 17978879
[TBL] [Abstract][Full Text] [Related]
4. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
Liu Y; West R; Weber JD; Colditz GA
Cancer; 2019 Sep; 125(18):3225-3233. PubMed ID: 31120565
[TBL] [Abstract][Full Text] [Related]
5. Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast.
Berkman A; F Cole B; Ades PA; Dickey S; Higgins ST; Trentham-Dietz A; Sprague BL; Lakoski SG
Breast Cancer Res Treat; 2014 Nov; 148(2):407-13. PubMed ID: 25326349
[TBL] [Abstract][Full Text] [Related]
6. Association of a Diagnosis of Ductal Carcinoma In Situ With Death From Breast Cancer.
Giannakeas V; Sopik V; Narod SA
JAMA Netw Open; 2020 Sep; 3(9):e2017124. PubMed ID: 32936299
[TBL] [Abstract][Full Text] [Related]
7. Ductal carcinoma in situ in African American versus Caucasian American women: analysis of clinicopathologic features and outcome.
Nassar H; Sharafaldeen B; Visvanathan K; Visscher D
Cancer; 2009 Jul; 115(14):3181-8. PubMed ID: 19452544
[TBL] [Abstract][Full Text] [Related]
8. Racial disparities in risk of second breast tumors after ductal carcinoma in situ.
Liu Y; Colditz GA; Gehlert S; Goodman M
Breast Cancer Res Treat; 2014 Nov; 148(1):163-73. PubMed ID: 25261293
[TBL] [Abstract][Full Text] [Related]
9. Patterns of care analysis among women with ductal carcinoma in situ in North Carolina.
Jackson LC; Camacho F; Levine EA; Anderson RT; Stewart JH
Am J Surg; 2008 Feb; 195(2):164-9. PubMed ID: 18096124
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for estrogen receptor positive ductal carcinoma in situ of the breast in African American women.
Bertrand KA; Bethea TN; Rosenberg L; Bandera EV; Khoury T; Troester MA; Ambrosone CB; Palmer JR
Breast; 2020 Feb; 49():108-114. PubMed ID: 31786415
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the ductal carcinoma in situ between White Americans and Chinese Americans.
Kuang XW; Sun ZH; Song JL; Zhu Z; Chen C
Medicine (Baltimore); 2021 Jan; 100(3):e24136. PubMed ID: 33546026
[TBL] [Abstract][Full Text] [Related]
12. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
13. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Virnig BA; Tuttle TM; Shamliyan T; Kane RL
J Natl Cancer Inst; 2010 Feb; 102(3):170-8. PubMed ID: 20071685
[TBL] [Abstract][Full Text] [Related]
14. Incidence of Ductal Carcinoma
Ryser MD; Hendrix LH; Worni M; Liu Y; Hyslop T; Hwang ES
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1316-1323. PubMed ID: 31186262
[TBL] [Abstract][Full Text] [Related]
15. Probabilities of death from breast cancer and other causes among female breast cancer patients.
Schairer C; Mink PJ; Carroll L; Devesa SS
J Natl Cancer Inst; 2004 Sep; 96(17):1311-21. PubMed ID: 15339969
[TBL] [Abstract][Full Text] [Related]
16. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.
Kerlikowske K; Molinaro A; Cha I; Ljung BM; Ernster VL; Stewart K; Chew K; Moore DH; Waldman F
J Natl Cancer Inst; 2003 Nov; 95(22):1692-702. PubMed ID: 14625260
[TBL] [Abstract][Full Text] [Related]
17. Molecular subtypes of ductal carcinoma in situ in African American and Caucasian American women: distribution and correlation with pathological features and outcome.
Sharaf Aldeen B; Feng J; Wu Y; Nassar Warzecha H
Cancer Epidemiol; 2013 Aug; 37(4):474-8. PubMed ID: 23639792
[TBL] [Abstract][Full Text] [Related]
18. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
[TBL] [Abstract][Full Text] [Related]
19. Mammographic density and risk of second breast cancer after ductal carcinoma in situ.
Habel LA; Capra AM; Achacoso NS; Janga A; Acton L; Puligandla B; Quesenberry CP
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2488-95. PubMed ID: 20929881
[TBL] [Abstract][Full Text] [Related]
20. Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.
Curigliano G; Disalvatore D; Esposito A; Pruneri G; Lazzeroni M; Guerrieri-Gonzaga A; Luini A; Orecchia R; Goldhirsch A; Rotmensz N; Bonanni B; Viale G
Ann Oncol; 2015 Apr; 26(4):682-687. PubMed ID: 25600567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
